Recent News

• 10.08.2025 - Noble Capital Markets Emerging Growth Virtual Equity Conference
• 10.08.2025 - Noble Capital Markets Emerging Growth Virtual Equity Conference
• 10.06.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
• 10.06.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
• 09.29.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
• 09.29.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
• 09.24.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
• 09.24.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
• 09.08.2025 - HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
• 09.08.2025 - HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Recent Filings

• 09.26.2025 - EX-99.1 EX-99.1
• 09.26.2025 - 8-K Current report
• 09.12.2025 - EX-99.1 EX-99.1
• 09.12.2025 - 8-K Current report
• 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.08.2025 - 8-K Current report